Diencephalic Syndrome
The medical term for the failure-to-thrive complication associated with pilomyxoid astrocytoma is "diencephalic syndrome" (also known as Russell's diencephalic syndrome). This syndrome occurs when hypothalamic/chiasmatic tumors, including pilomyxoid astrocytoma, cause severe weight loss and failure to thrive despite normal or even increased appetite 1, 2, 3.
Clinical Presentation
Diencephalic syndrome manifests as a constellation of findings:
- Extreme weight loss with preserved linear growth - the hallmark feature is severe malnutrition (often third-degree) with maintenance of height and head circumference 1, 3
- Normal or increased appetite - distinguishes this from other causes of failure to thrive
- Associated neurological signs including nystagmus, visual field defects, optic pallor, emesis, and developmental regression 2, 4
- Hypotonia and loss of previously attained milestones may occur 4
Tumor Characteristics in Diencephalic Syndrome
When pilomyxoid astrocytoma presents with diencephalic syndrome, specific features are notable:
- Location: Suprasellar region involving hypothalamus and optic chiasm 1, 2, 3
- Size: These tumors tend to be large (median maximum diameter 3.5 cm) 2
- Age: Typically affects very young children (mean age 26 months, range 10-17 months) 2, 3
- Imaging: Hypointense on T1, hyperintense on T2/FLAIR, with homogeneous enhancement 1, 4
Important Clinical Pitfall
Diagnosis is frequently delayed because diencephalic syndrome is a rare cause of failure to thrive in childhood 2, 3. Children are often initially worked up for more common causes of malnutrition such as intestinal malabsorption syndrome, leading to delayed neuroimaging 3. The key is recognizing that failure to thrive with preserved linear growth and normal appetite should prompt immediate brain MRI to evaluate for hypothalamic pathology.
Prognosis Considerations
Astrocytomas associated with diencephalic syndrome demonstrate more aggressive behavior than typical low-grade astrocytomas in this region - they are larger, occur at younger ages, and show higher rates of recurrence and metastases 2. In one series, 5 of 9 patients had recurrent disease and 2 died during follow-up 2.